Nutex Health Inc. (NUTX) vs Starling Oncology, Inc. (STLN)
- Nutex Health Inc. NUTX 181.20 −6.42%
- Starling Oncology, Inc. STLN 3.51 −47.61%
Nutex Health Inc. and Starling Oncology, Inc. are both Medical Care Facilities companies. Nutex Health Inc. is the larger, with a market value of $1.3B against $669.9M — 2.0× the size. Starling Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; Nutex Health Inc. trades at 6.9×. Starling Oncology, Inc. grew revenue faster over the last twelve months: 34.6% against 6.88%. Nutex Health Inc. has the higher net margin (21.3% vs −5.73%) and the higher return on invested capital (37.9% vs 0.00%). Across the 19 metrics below, Nutex Health Inc. leads on 11 and Starling Oncology, Inc. on 8.
Valuation
Profitability
| Metric | NUTX | STLN | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 51.26% | 0.00% | 30.56% |
| Operating margin | 43.02% | (3.39%) | 6.62% |
| Net margin | 21.25% | (5.73%) | 3.08% |
| Free cash flow margin | 32.38% | 3.03% | 7.22% |
| Return on equity | 42.63% | 143.21% | 6.41% |
| Return on assets | 19.93% | (20.23%) | 2.78% |
| Return on invested capital | 37.92% | 0.00% | 7.44% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack